

February 2025; papers of the month
11 snips Feb 1, 2025
This month's discussion dives into cutting-edge research on seizure management, particularly the intriguing potential of ketamine alongside midazolam. The presenters also explore oxygen therapy strategies in trauma care, weighing the benefits of liberal versus targeted approaches. Lastly, the podcast scrutinizes transfusion strategies for traumatic brain injury patients, analyzing their effects on recovery and overall quality of life. With a blend of humor and clinical insight, this dialogue promises to keep medical enthusiasts engaged!
AI Snips
Chapters
Transcript
Episode notes
Status Epilepticus Risks
- Status epilepticus, seizures lasting over five minutes, carries high mortality and morbidity risks.
- Benzodiazepines are first-line treatment, but they fail in about a third of patients.
Ketamine for Seizures
- Consider ketamine as an addition to midazolam for convulsive status epilepticus.
- This retrospective study suggests ketamine may improve seizure termination rates.
Study Limitations
- The study's change in midazolam dosage and the single-center US setting limit generalizability to UK practice.
- Initial benzodiazepine doses in the study were lower than standard UK practice.